Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rallybio Corporation - Common Stock
(NQ:
RLYB
)
0.2500
-0.0018 (-0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rallybio Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
Rallybio to Present at Upcoming Investor Conferences in November
November 11, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Pricing of $50 Million Public Offering
November 10, 2022
From
Rallybio
Via
Business Wire
Rallybio Announces Proposed Public Offering
November 10, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio's Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets
September 28, 2022
Via
Benzinga
Rallybio Reports Third Quarter 2022 Financial Results
November 07, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
November 07, 2022
From
Rallybio Corporation
Via
Business Wire
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
October 05, 2022
Losers
Via
Benzinga
Peering Into Rallybio's Recent Short Interest
October 04, 2022
Rallybio's (NASDAQ:RLYB) short percent of float has fallen 4.94% since its last report. The company recently reported that it has 638 thousand shares sold short, which is 2.5% of all regular shares...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 04, 2022
Gainers
Via
Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Via
Benzinga
FaZe Holdings, AXT And Some Other Big Stocks Moving Lower On Tuesday
October 04, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 700 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
September 28, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the 2022 Wells Fargo Healthcare Conference
August 31, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Reports Second Quarter 2022 Financial Results
August 08, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
August 02, 2022
From
Rallybio Corporation
Via
Business Wire
69 Biggest Movers From Friday
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 03, 2022
Via
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
June 03, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Via
Benzinga
Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer
June 02, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at Upcoming Investor Conferences in June
June 01, 2022
From
Rallybio Corporation
Via
Business Wire
58 Biggest Movers From Yesterday
May 24, 2022
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
Rallybio Reports First Quarter 2022 Financial Results
May 10, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
May 10, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
April 04, 2022
From
Rallybio Corporation
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
March 28, 2022
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 23, 2022
On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was...
Via
Benzinga
How Is The Market Feeling About Rallybio Corporation - Common Stock?
March 21, 2022
Rallybio Corporation - Common Stock's (NASDAQ:RLYB) short percent of float has fallen 14.21% since its last report. The company recently reported that it has 446.60 thousand...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 17, 2022
Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to...
Via
Benzinga
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results
March 15, 2022
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the Cowen 42nd Annual Health Care Conference
February 28, 2022
From
Rallybio Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.